Correvio Pharma (CORV) Stock: Headed Up On Regulatory Update

Correvio Pharma Corp (NASDAQ: CORV) is having an incredibly strong start to the trading session this morning after the company announced a regulatory update surroundingĀ BRINAVESSĀ®. Of course, the update was positive, leading to excitement among investors and sending the stock on a run for the top. Today, we’ll talk about: The regulatory update; what we’re … Read more